Biovest International
Recent activities involving Biovest International announced
Published in Lab Law Weekly, December 15th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Biovest International.
Report 1: A majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., (ABPI), Biovest International, Inc., (BVTI) has launched its AutovaxID automated cell culture device for commercial sale.
AutovaxID is a fully automated, reusable instrument that employs a fully disposable, closed-system cell-growth chamber incorporating a hollow-fiber cell-growth cartridge. This unique bioreactor replaces conventional stainless steel, glass, and plastic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-12-15)
More Articles from Lab Law Weekly
- Business & Finance
AutoImmune reports loss of $0.00 per share - Business & Finance
Celesio records, as anticipated, weaker growth in third quarter - Business & Finance
Cellegy reports third quarter financial results - Business & Finance
Chembio Diagnostics announces 8% third quarter revenue increase over same period last year - Business & Finance
DOV Pharmaceutical announces net loss of $17.5 million in third quarter - Business Update
Amerigroup to file form 12b-25 notification of late filing - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
